BioAegis Therapeutics Awarded $20 Million BARDA DRIVe Contra

BioAegis Therapeutics Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)

BioAegis Therapeutics Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Susan Levinson , Steven Cordovano , Christine Lagana , Human Services , Biomedical Advanced Research , Society Vulnerability To Global Pandemics , Division Of Research , Bioaegis Therapeutics Inc , Us Department Of Health , Development Authority , Administration For Strategic Preparedness , Aegis Therapeutics Awarded , Advance Gelsolin , Immune Regulator , Acute Respiratory Distress Syndrome , Aegis Therapeutics , Strategic Preparedness , Reduce Society , Respiratory Distress Syndrome , Multitasking Protein , Complex Condition , Chief Executive Officer ,